期刊文献+

TGF-β1、Serpine1、vWF、PF4在深静脉血栓患者血白细胞和血小板中的表达 被引量:5

The TGF-β1,serpine1,vHF and PF4 expression of leucocytes and platelets in patients with deep vein thrombosis
下载PDF
导出
摘要 目的研究转化生长因子(TGF)-β1、纤溶酶原激活物抑制因子1(Serpine1)、血管性血友病因子(vWF)、血小板第4因子(PF4)mRNA在深静脉血栓患者血白细胞和血小板中的表达变化及在血栓形成中的作用。方法将患者分为血栓形成组15例和无血栓形成组15例,另选正常对照组15例。采集患者血栓形成和不形成时相应状态的血液样本,提取血白细胞和血小板中总RNA,并反转录为cDNA,采用PCR和实时-PCR技术,检测TGF-β1、Serpine1、vWF、PF4 mRNA在各组中的表达。结果 PCR和实时-PCR的检测结果一致,TGF-β1、Serpine1、vWF、PF4 mRNA在血栓形成组中的表达明显高于无血栓形成组和正常对照组(P<0.05),而在无血栓形成组和正常对照组间则差异无统计学意义(P>0.05)。结论血白细胞和血小板中TGF-β1、Serpine1、vWF、PF4 mRNA表达上调可能在深静脉血栓形成中发挥了重要作用。 Objective To study the change of transformation growth factor-β1 (TGF-β1), serpinel, yon Willebrand (vWF) and platelet factor 4 (PF4) expression of leucocytes and platelets in patients with deep vein thrombosis (DVT) and its role in the formation of thrombosis. Methods A total of 45 patients were enrolled in this study. The patients were divided into normal control group (n = 15), thrombosis group (n = 15) and non-thrombosis group (n = 15). Blood samples were collected in the thrombosis state as well as in the non-thrombosis state in all patients, at the same time the total RNA was extracted from the leukocytes and platelets, and its reverse transcription to cDNA was conducted. By using PCR and realtime PCR technique, the expression of TGF-β1, serpinel, vWF and PF4 in each group was determined separately. The results were analyzed. Results The results obtained from PCR technique were consistent with those obtained from real-time PCR technique. The TGF-β1, serpinel, vWF and PF4 mRNA expression of leukocytes and platelets in thrombosis group was significantly higher than that in non-thrombosis group as well as in normal control group (P 〈 0.05), while no statistically significant difference in the expression existed between the non - thrombosis group and normal control group (P 〉 0.05). Conclusion The results from present study indicate that the up-regulated TGF - β1, serpinel, vWF and PF4 expression in leukocytes and platelets may play an important role in the formation of deep vein thrombosis.
出处 《介入放射学杂志》 CSCD 北大核心 2013年第3期185-189,共5页 Journal of Interventional Radiology
基金 国家自然科学基金资助项目(30960389 81060151 81160236) 云南省科技厅-昆明医学院联合项目(2009cd159) 云南省重点新产品项目开发计划项目(2010BC010)
关键词 深静脉血栓 转化生长因子-β1 纤溶酶原激活物抑制因子1 血管性血友病因子 血小板第4因子 deep vein thrombosis tra-nsformation growth factor-β1 serpinel von Willebrand platelet factor 4
  • 相关文献

参考文献13

  • 1顾建平,徐克,滕皋军.下肢深静脉血栓形成介入治疗规范的专家共识[J].介入放射学杂志,2011,20(7):505-510. 被引量:114
  • 2李炯,唐博.静脉血栓栓塞生物标志物的研究进展[J].重庆医学,2012,41(22):2326-2328. 被引量:3
  • 3Esmon CT. Basic mechanisms and pathogenesis of venous thrombosis[J]. Blood Rev, 2009, 23:225 -229.
  • 4Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C (T) method [J]. Nat Protoc, 2008, 3:1101 - 1108.
  • 5Xu AG, Xu RM, Lu CQ, et al. Correlation of yon willebrand factor gene polymorphism and coronary heart disease [J]. Mol Med Report, 2012, 6:1107 - 1110.
  • 6van Galen KP, Tuinenburg A, Smeets EM, et al. Von willebrand factor deficiency and atherosclerosis [J]. Blood Rev, 2012, 26.. 189 - 196.
  • 7Aidoudi S, Bikfalvi A. Interaction of PF4 (CXCL4) with the vasculature: a role in atherosclerosis and angiogenesis [J]. Thromb Haemost, 2010, 104:941 - 948.
  • 8Kowalska MA, Rauova L, Poncz M. Role of the platelet chemokine platelet factor 4 (PF4) in hemostasis and thrombosis [J]. Thromb Res, 2010, 125:292 -296.
  • 9Brogren H, Karlsson L, Andersson M, et al. Platelets synthesize large amounts of active plasminogen activator inhibitor 1 [J]. Blood, 2004, 104:3943 - 3948.
  • 10Mehzer ME, Lisman T, de Groot PG, et al. Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI- 1 [J]. Blood, 2010, 116:113 - 121.

二级参考文献46

  • 1夏爽,祁吉,雷新玮,温连庆,李一鸣,刘继生.16层螺旋CT对肺动脉栓塞及下肢静脉血栓行联合成像的技术优势[J].中华放射学杂志,2004,38(11):1164-1168. 被引量:49
  • 2顾建平,何旭,楼文胜,陈亮,苏浩波,陈国平.经腘静脉穿刺介入治疗髂股静脉阻塞[J].中华放射学杂志,2005,39(9):921-924. 被引量:47
  • 3顾建平,何旭,楼文胜,陈亮,苏浩波,陈国平,宋进华.介入治疗576例下肢深静脉血栓形成[J].南京医科大学学报(自然科学版),2006,26(12):1261-1264. 被引量:21
  • 4张春强,黄河,赵学凌,何飞,殷亮,赵智,唐锡章,周兆文,李世和.两种创伤性深静脉血栓大鼠模型中炎症相关基因的表达研究[J].生物医学工程研究,2007,26(1):66-70. 被引量:8
  • 5Schulman S, Lindmarker P, Holmstrom M, et al. Post- thromotic syndrome, recurrence, anddeath lO years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months[J]. Thromb Haemost, 2006,4 (4) : 734-742.
  • 6Douketis J, Tosetto A, Marcucci M, et al. Risk of recur- rence after venous thromboembolism in men and women: patient level meta-analysis[J]. BMJ, 2011,342 : 611.
  • 7Cushman M, Douketis J, Tosetto A, et al. Patient-level recta-analysis: effect of measurement timing, threshold, andpatient age on ability of D-dimer testing to assess re- currence risk after unprovoked venous thromboembolism [J]. Ann Intern Med, 2010,153 (8) : 523-531.
  • 8Verhovsek M,Douketis JD,Yi Q, et al. D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism [J ]. Ann Intern Med,2008,149(7) :481-490.
  • 9Cosmi B, Legnani C, Cini M, et al. D-dimer and residual vein obstruction as risk factors for recurrence during and after anticoagulation withdrawal in patients with a first episode of provoked deep-vein thrombosis [J]. Thromb Haemost, 2011,105(5) :837-845.
  • 10Eichinger S, Heinze G, Jandeck LM, et al. Risk assess- ment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism:the vienna prediction model[J]. Circulation, 2010,121 (14) : 1630-1636.

共引文献118

同被引文献51

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部